About ZetrOZ
ZetrOZ is a company based in Trumbull (United States) founded in 2009. ZetrOZ has raised $6.78 million across 9 funding rounds from investors including NIH, Horizon Tech Finance and NSBRI. The company has 10 employees as of December 31, 2022. ZetrOZ offers products and services including sam® Sport, sam® Pro 2.0, sam® coupling patches, and sam® X1. ZetrOZ operates in a competitive market with competitors including Theranica, Bone Health Technologies, Mainstay Medical, Sooma Oy and SPR Therapeutics, among others.
- Headquarter Trumbull, United States
- Employees 10 as on 31 Dec, 2022
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zetroz Systems Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.78 M (USD)
in 9 rounds
-
Latest Funding Round
Not available
-
Investors
NIH
& 8 more
-
Employee Count
10
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ZetrOZ
ZetrOZ offers a comprehensive portfolio of products and services, including sam® Sport, sam® Pro 2.0, sam® coupling patches, and sam® X1.
Wearable ultrasound for sports injury healing and pain relief.
Advanced ultrasound device for professional tissue recovery applications.
Patches enhancing ultrasound device functionality for better treatment.
Ultrasound device targeted for chronic pain management and healing.
People of ZetrOZ
Unlock access to complete
Unlock access to complete
Funding Insights of ZetrOZ
ZetrOZ has successfully raised a total of $6.78M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ZetrOZ
ZetrOZ has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Horizon Tech Finance and NSBRI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Structured debt is provided to life sciences and technology firms.
|
Locked | Locked | Locked | |
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Locked | Locked | Locked | |
|
A network for angel investors and entrepreneurs is provided.
|
Locked | Locked | Locked |
Investor details for ZetrOZ
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ZetrOZ
Investment portfolio details for ZetrOZ
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ZetrOZ
Detailed financials for ZetrOZ
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zetroz Comparisons
Peer comparison for ZetrOZ
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ZetrOZ
ZetrOZ operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theranica, Bone Health Technologies, Mainstay Medical, Sooma Oy and SPR Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic devices for pain management are developed and manufactured.
|
|
| Locked | Locked | Locked |
Bone Health Technologies creates a wearable device to treat osteopenia and prevent osteoporosis.
|
|
| Locked | Locked | Locked |
Provider of rehabilitation solutions for patients and doctors
|
|
| Locked | Locked | Locked |
Non-invasive neuromodulation therapies
|
|
| Locked | Locked | Locked |
Pioneers non-invasive devices for chronic pain relief through medical innovation.
|
Detailed competitors of ZetrOZ
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zetroz
Complete news archive for ZetrOZ
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ZetrOZ
ZetrOZ was founded in 2009 and raised its 1st funding round 1 year after it was founded.
ZetrOZ is headquartered in Trumbull, United States. It is registered at Trumbull, Connecticut, United States.
ZetrOZ is a funded company, having raised a total of $6.78M across 9 funding rounds to date.
As of Dec 31, 2022, the latest employee count at ZetrOZ is 10.
ZetrOZ was founded in 2009 and is based in Trumbull, United States. Operations focus on the bioelectronics sector, where two wearable products are provided to deliver sustained acoustic medicine. These address conditions including pain relief, muscle spasm reduction, joint contracture treatment, and enhanced local circulation. The company serves medical applications through non-invasive therapeutic devices.
ZetrOZ's top competitors include Theranica, Mainstay Medical and Nufabrx.
ZetrOZ offers sam® Sport, sam® Pro 2.0, sam® coupling patches, and sam® X1.
ZetrOZ has 9 investors. Key investors include NIH, Horizon Tech Finance, NSBRI, Connecticut Innovations, and Angel Investor Forum.